본문 바로가기

Therapeutic Effect of Quinacrine, an Antiprotozoan Drug, by Selective Suppression of p-CHK1/2 in p53-Negative Malignant Cancers

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q1
저널
MOLECULAR CANCER RESEARCH16(6) · pp.935 · 2018
피인용
Web of Science 14Scopus 17
FWCI (Scopus)
0.61
JCR IF
JCR 2017 4.597
ISSN
1541-7786

저자

  1. 박소영제1저자Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, South Korea
  2. 오아영Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, South Korea
  3. 조정현Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, South Korea
  4. 윤민호Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, South Korea
  5. 우태균Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, South Korea
  6. 강소미Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, South Korea
  7. Lee, Ho-YoungDepartment of Nuclear Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea
  8. 정연진College of Pharmacy, Pusan National University, Busan, South Korea
  9. 박범준교신저자Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, South Korea

초록

Quinacrine (QNC), antiprotozoan drug commonly used against Malaria and Giardiasis, has been recently tried for rheumatics and prion diseases via drug repositioning. In addition, several reports suggest antitumor effects of QNC through suppression of NF-kappa B and activation of p53. This study demonstrates the anticancer effect of QNC via a novel pathway through the elimination of checkpoint kinase 1/2 (Chk1/2) under p53-in-activated conditions. Inhibition of p53 by PFT-alpha or siRNA promotes QNC-induced apoptosis in normal fibroblast and p53-intact cancer cells. Considering that Chk1/2 kinases exert an essential role in the control of cell cycle, inhibition of Chk1/2 byQNC may induce cell death via uncontrolled cell cycle progression. Indeed, QNC reduces Chk1/2 expression under p53-impaired cancer cells and induces cell death in the G(2)-M phase. QNC increases the binding between p-Chk1/2 and beta-TrCP and promotes proteasome-dependent degradation. Moreover, QNC treatment displayed antitumor effects in a Villin-Cre; p53(+/LSL-R172H) intestinal cancer mouse model system as well as HCT116 p53(-/-) xenografts. (C) 2018 AACR.

키워드

NF-KAPPA-BRENAL-CELL CARCINOMAP53 SUPPRESSIONSMALL MOLECULESATM ACTIVATIONMOUSE MODELSDNA-BINDINGCHECKPOINTRESISTANCEINHIBITION

식별자

Scopus EID
2-s2.0-85048244820
WoS UID
000433914400002